Zoetis Inc

ZTS · NYSE · Healthcare / Drug Manufacturers - Specialty & Generic

83.82USD+0.86 (+1.04%)

Price History

Full chart

Market Stats

Previous Close82.96

Open83.50

Day Range82.27 – 83.85

52-Week Range68.31 – 141.64

Volume3.11M

Market Cap32.94B

P/E (TTM)13.11

Forward P/E13.19

EPS6.08

Dividend Yield2.69%

Beta0.74

50-Day Avg75.05

200-Day Avg93.53

About

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMs. Kristin C. Peck
Employees14.50K
Headquarters10 Sylvan Way, Parsippany, NJ, United States, 07054, USA
Websitehttps://www.zoetis.com

Leadership

Ms. Kristin C. PeckCEO & Director · b. 1971
Ms. Roxanne LaganoExecutive VP, General Counsel & Corporate Secretary · b. 1965
Mr. Wetteny N. Joseph CPASpecial Advisor to the CEO · b. 1972
Dr. Robert J. Polzer Ph.D.Scientific Advisor · b. 1969
Mr. Jamie BrannanExecutive VP & Chief Commercial Officer · b. 1973
Mr. James K. SaccaroExecutive VP, CFO & COO · b. 1973
Mr. Keith SarbaughExecutive VP & Chief Digital and Technology Officer · b. 1979
Mr. Steven FrankVice President of Investor Relations
Ms. Julie A. FullerExecutive VP, Chief Human Resources Officer & Global Operations · b. 1973
Mr. Abhay U. NayakExecutive VP & President of U.S. Commercial Operations · b. 1988

Financials

Income Statement

Currency: USD	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	2.76B	3.58B	4.23B	4.34B	4.56B	4.79B	4.76B	4.89B	5.31B	5.83B	6.26B	6.67B	7.78B	8.08B	8.54B	9.26B	9.47B
Growth (%)	-	+29.78%	+18.17%	+2.43%	+5.19%	+4.91%	-0.42%	+2.58%	+8.57%	+9.76%	+7.47%	+6.63%	+16.49%	+3.91%	+5.74%	+8.33%	+2.28%
Cost of Revenue	1.06B	1.50B	1.70B	1.62B	1.73B	1.78B	1.80B	1.75B	1.86B	2.03B	2.15B	2.22B	2.46B	2.60B	2.71B	2.86B	2.79B
Gross Profit	1.70B	2.08B	2.54B	2.72B	2.83B	3.01B	2.97B	3.14B	3.44B	3.80B	4.11B	4.46B	5.31B	5.48B	5.83B	6.40B	6.67B
Gross Margin	61.67%	58.21%	59.96%	62.71%	62.11%	62.86%	62.27%	64.30%	64.88%	65.18%	65.70%	66.79%	68.31%	67.77%	68.28%	69.10%	70.49%
Operating Expense	1.42B	1.78B	1.85B	1.86B	2.01B	2.04B	1.89B	1.74B	1.72B	1.92B	2.10B	2.19B	2.51B	2.55B	2.77B	3.00B	3.08B
Operating Income	281.00M	309.00M	684.00M	854.00M	821.00M	970.00M	1.08B	1.40B	1.73B	1.88B	2.02B	2.27B	2.80B	2.93B	3.07B	3.39B	3.60B
Operating Margin	10.18%	8.63%	16.16%	19.70%	18.00%	20.27%	22.71%	28.72%	32.54%	32.29%	32.24%	33.99%	36.05%	36.24%	35.92%	36.65%	38.00%
EBITDA	2.00M	400.00M	635.00M	941.00M	1.01B	1.14B	868.00M	1.63B	1.94B	2.21B	2.46B	2.69B	3.17B	3.36B	3.69B	3.87B	4.07B
EBITDA Margin	0.07%	11.17%	15.00%	21.70%	22.14%	23.85%	18.22%	33.43%	36.59%	37.94%	39.22%	40.24%	40.79%	41.56%	43.13%	41.83%	42.98%
Net Income	-100.00M	110.00M	245.00M	436.00M	504.00M	583.00M	339.00M	821.00M	864.00M	1.43B	1.50B	1.64B	2.04B	2.11B	2.34B	2.49B	2.67B
Net Income Margin	-3.62%	3.07%	5.79%	10.06%	11.05%	12.18%	7.11%	16.80%	16.28%	24.52%	23.96%	24.54%	26.20%	26.16%	27.43%	26.86%	28.23%
R&D	368.00M	411.00M	427.00M	409.00M	399.00M	396.00M	364.00M	376.00M	382.00M	432.00M	457.00M	463.00M	508.00M	539.00M	614.00M	686.00M	698.00M
R&D as % of Total Revenue	13.33%	11.47%	10.09%	9.43%	8.75%	8.28%	7.64%	7.69%	7.20%	7.42%	7.30%	6.94%	6.53%	6.67%	7.19%	7.41%	7.37%
Interest Expense	26.00M	37.00M	36.00M	31.00M	113.00M	117.00M	124.00M	166.00M	175.00M	212.00M	242.00M	249.00M	236.00M	237.00M	258.00M	242.00M	243.00M
Interest Expense % of Total Revenue	0.94%	1.03%	0.85%	0.71%	2.48%	2.45%	2.60%	3.40%	3.30%	3.64%	3.87%	3.73%	3.03%	2.93%	3.02%	2.61%	2.57%

Balance Sheet

Currency: USD	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	-	5.28B	5.71B	6.26B	6.56B	6.59B	7.91B	7.65B	8.59B	10.78B	11.54B	13.61B	13.90B	14.93B	14.29B	14.24B	15.47B
Total Liabilities	-	1.94B	1.98B	2.22B	5.60B	5.25B	6.82B	6.15B	6.80B	8.59B	8.84B	9.84B	9.36B	10.52B	9.29B	9.47B	12.14B
Total Equity	-	3.34B	3.72B	4.03B	940.00M	1.31B	1.07B	1.50B	1.79B	2.19B	2.71B	3.77B	4.54B	4.41B	5.00B	4.77B	3.33B
Cash	-	63.00M	79.00M	317.00M	610.00M	882.00M	1.15B	727.00M	1.56B	1.60B	1.93B	3.60B	3.48B	3.58B	2.04B	1.99B	2.31B
Total Debt	-	711.00M	575.00M	582.00M	3.66B	3.63B	4.87B	4.47B	4.95B	6.45B	6.61B	7.36B	6.74B	8.09B	6.75B	6.74B	9.49B
Net Debt	-	648.00M	496.00M	265.00M	3.05B	2.75B	3.71B	3.74B	3.39B	4.86B	4.68B	3.76B	3.26B	4.51B	4.72B	4.76B	7.18B

Cash Flow

Currency: USD	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	98.00M	254.00M	497.00M	454.00M	681.00M	626.00M	664.00M	713.00M	1.35B	1.79B	1.79B	2.13B	2.21B	1.91B	2.35B	2.95B	2.90B
Investing Cash Flow	-1.82B	-9.00M	-449.00M	-135.00M	-179.00M	-187.00M	-1.11B	-214.00M	-270.00M	-2.26B	-504.00M	-572.00M	-458.00M	-883.00M	-777.00M	-315.00M	-748.00M
Financing Cash Flow	1.82B	-277.00M	-30.00M	-78.00M	-200.00M	-154.00M	755.00M	-903.00M	-251.00M	533.00M	-951.00M	123.00M	-1.86B	-904.00M	-3.11B	-2.66B	-1.87B
Capital Expenditure	135.00M	124.00M	135.00M	126.00M	184.00M	195.00M	224.00M	216.00M	224.00M	338.00M	460.00M	453.00M	477.00M	586.00M	732.00M	655.00M	621.00M
Free Cash Flow	-37.00M	130.00M	362.00M	328.00M	497.00M	431.00M	440.00M	497.00M	1.12B	1.45B	1.33B	1.67B	1.74B	1.33B	1.62B	2.30B	2.28B
Dividends Paid	101.00M	207.00M	416.00M	63.00M	98.00M	146.00M	168.00M	188.00M	206.00M	243.00M	314.00M	380.00M	474.00M	611.00M	692.00M	786.00M	889.00M
FCF to OCF	-37.76%	51.18%	72.84%	72.25%	72.98%	68.85%	66.27%	69.71%	83.36%	81.12%	74.37%	78.69%	78.45%	69.35%	68.89%	77.82%	78.62%
Dividend Paid to FCF	-272.97%	159.23%	114.92%	19.21%	19.72%	33.87%	38.18%	37.83%	18.36%	16.74%	23.52%	22.71%	27.30%	46.08%	42.69%	34.20%	38.94%

Earnings

Report Date	Mar 27, 2013	Apr 30, 2013	Aug 6, 2013	Nov 5, 2013	Feb 11, 2014	May 6, 2014	Aug 5, 2014	Nov 4, 2014	Feb 11, 2015	May 5, 2015	Aug 4, 2015	Nov 3, 2015	Feb 16, 2016	May 4, 2016	Aug 3, 2016	Nov 2, 2016	Feb 16, 2017	May 4, 2017	Aug 8, 2017	Nov 2, 2017	Feb 15, 2018	May 2, 2018	Aug 2, 2018	Nov 1, 2018	Feb 14, 2019	May 2, 2019	Aug 6, 2019	Nov 7, 2019	Feb 13, 2020	May 6, 2020	Aug 6, 2020	Nov 5, 2020	Feb 16, 2021	May 6, 2021	Aug 5, 2021	Nov 4, 2021	Feb 15, 2022	May 5, 2022	Aug 4, 2022	Nov 3, 2022	Feb 14, 2023	May 4, 2023	Aug 8, 2023	Nov 2, 2023	Feb 13, 2024	May 2, 2024	Aug 6, 2024	Nov 4, 2024	Feb 13, 2025	May 6, 2025	Aug 5, 2025	Nov 4, 2025	Feb 12, 2026	May 7, 2026	Aug 6, 2026	Nov 5, 2026
EPS Estimate	0.27	0.33	0.36	0.34	0.34	0.37	0.38	0.37	0.36	0.37	0.38	0.40	0.39	0.41	0.44	0.46	0.45	0.48	0.53	0.62	0.66	0.69	0.70	0.77	0.77	0.79	0.82	0.89	0.88	0.87	0.65	0.92	0.87	1.04	1.09	1.11	0.96	1.22	1.22	1.24	1.15	1.25	1.31	1.36	1.32	1.34	1.48	1.46	1.36	1.40	1.61	1.62	1.40	1.62	1.84	1.51
EPS Actual	0.11	0.36	0.36	0.34	0.36	0.38	0.38	0.41	0.40	0.41	0.43	0.50	0.43	0.48	0.49	0.52	0.47	0.53	0.53	0.65	0.69	0.75	0.77	0.83	0.79	0.88	0.90	0.94	0.92	0.95	0.89	1.10	0.91	1.26	1.19	1.25	1.00	1.32	1.20	1.21	1.15	1.31	1.41	1.36	1.24	1.38	1.56	1.58	1.40	1.48	1.76	1.70	1.48	1.53	1.87	-
Surprise	-59.26%	9.09%	0.00%	0.00%	5.88%	2.70%	0.00%	10.81%	11.11%	10.81%	13.16%	25.00%	10.26%	17.07%	11.36%	13.04%	4.44%	10.42%	0.00%	4.84%	4.55%	8.70%	10.00%	7.79%	2.60%	11.39%	9.76%	5.62%	4.55%	9.20%	36.92%	19.57%	4.60%	21.15%	9.17%	12.61%	4.17%	8.20%	-1.64%	-2.42%	0.00%	4.80%	7.63%	0.00%	-6.06%	2.99%	5.41%	8.22%	2.94%	5.71%	9.32%	4.94%	5.71%	-5.56%	1.63%	-
Timing	-	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market

Key Statistics & Ratios

Market Cap32.94B

Enterprise Value40.13B

Trailing P/E13.11

Forward P/E13.19

PEG Ratio14.67

Price / Sales3.46

Price / Book10.34

EPS6.08

Book Value7.60

Revenue (TTM)9.53B

Gross Profit (TTM)6.83B

EBITDA4.07B

Profit Margin27.69%

Operating Margin40.72%

Return on Equity64.91%

Return on Assets15.35%

Shares Outstanding413.22M

Shares Float412.37M

Beta0.74

Dividend Yield2.69%

Dividend Rate2.12

Payout Ratio43.44%

Analyst Ratings

Hold

Based on 16 analystsTarget 88.38

Strong Buy
2
Buy
3
Hold
11

Ownership Breakdown

Institutions: 100.27%
Insiders: 0.16%
Retail / Other: 0.00%

Top Institutional Holders

BlackRock Inc
39.43M9.54%
Vanguard Capital Management, LLC
26.03M6.30%
Vanguard Portfolio Management, LLC
23.86M5.77%
State Street Corp
19.67M4.76%
State Farm Mutual Automobile Ins Co
15.89M3.85%
Geode Capital Management, LLC
13.29M3.22%
Wellington Management Company LLP
9.42M2.28%
Morgan Stanley - Brokerage Accounts
8.88M2.15%
Nordea Investment Mgmt Bank Demark A/s
6.59M1.60%
Deutsche Bank AG
5.85M1.42%
Northern Trust Corp
5.54M1.34%
Amvescap Plc.
5.52M1.34%
Fidelity International Ltd
5.38M1.30%

Top Fund Holders

Vanguard MStar Total Stk Mkt Idx Invest
11.81M2.86%
Vanguard 500 Index Investor
10.85M2.63%
Vanguard MStar Mid Cap Index Instl
7.96M1.93%
Vanguard Equity-Income Inv
6.11M1.48%
iShares Core S&P 500 ETF
5.51M1.33%
Fidelity 500 Index
5.44M1.32%
State Street® SPDR® S&P 500® ETF
5.07M1.23%

Dividends

20264×

0.53Oct 30, 20260.53Jul 20, 20260.53Apr 20, 20260.53Jan 20, 2026

20254×

0.50Oct 31, 20250.50Jul 18, 20250.50Apr 21, 20250.50Jan 21, 2025

20244×

0.43Oct 31, 20240.43Jul 18, 20240.43Apr 18, 20240.43Jan 18, 2024

20234×

0.38Oct 31, 20230.38Jul 20, 20230.38Apr 20, 20230.38Jan 19, 2023

20224×

0.33Oct 31, 20220.33Jul 20, 20220.33Apr 20, 20220.33Jan 19, 2022

20214×

0.25Oct 28, 20210.25Jul 20, 20210.25Apr 20, 20210.25Jan 19, 2021